Font Size: a A A
Keyword [tumor-specific]
Result: 61 - 80 | Page: 4 of 7
61. The Screening Of Tumor Specific PK-M2and Study On Its Basic Characterisitcs In Acute Leukemia
62. The Construction Of Tumor Specific Promoter Survivin In Regulation Of Shrna Adenovirus And The Inhibition Of The Expression Of CD133Gene In HEPG-2Cells
63. Research On Immunologic Adjuvant Effects Of Cinobufagin And Its Enhancement Function Of Tumor-specific Immune Response
64. Construction Of The Tumor-Specific Imagining System And Trans-Kingdom Thya Homologous Recombination Vector In Lactococcus Lactis
65. Research Of Tumor Immune Response Mediates The Tumor-specific CD8~+T Cell And Regulatiry T Cell In Galectin-9Deficient Mice
66. Experimental Study Of Ulinastatin Combined With Tumor Specific CTL Treatment On Cancer Cachexia In Mice
67. The Study On The Detection Of Serum VEGF And TSGF In The Diagnosis Of Primary Liver Cancer And The Eurative Effect And Evaluation After TACE
68. Conditional Gene Silencing Using A Tumor-specific And Heat-inducible SiRNA System
69. Construction And Identification Of Tumor-specific Replication-defective Recombinant Adenovirus In Kidney
70. Construction And Identification Of Coxsackie Adenovirus Receptor-independent Tumor-specific Replication-defective Recombinant Adenovirus In Kidney
71. The Observation Of Clinical Effect Of Sequential Therapy With "Neiyitingfang" And "Wenhuazhitongfang" Of Adenomyosis Dysmenorrhea And Its Influence On Serum TSGF
72. Integrin ?v?6-targeted Immunoliposomes:A Novel Approach For Tumor-Specific Drug Delivery And Therapy In Colon Carcinoma
73. Identification Of NDGA-derived NDGA-P21 Anti-glioma Effect And Characterization Of CD4~+ T Cell In Human Glioma Microenvironment
74. Tumor-specific Antigen MAGE-A9 On Biological Behavior Of Ovarian Cancer And Its Mechanism Underlying Resistance To Chemotherapy
75. Exploration Of The Feasibility Of Peptide/Major Histocompatibility Complex (pMHC) As Antibody-drug Conjugates (ADCs) Target
76. Light-Triggered Nanoparticles As Tumor-Specific Theranostics Carrier
77. Differentiate Various Cancer Types And Quantification Circulating Tumor Cells In Human Blood Via Detection Of Tumor Specific DNA Methylation Sites
78. MGMT Promoter Methylation In Serum And Cerebrospinal Fluid As A Tumor-specific Biomarker Of Glioma
79. Clinicopathological Features Of Renal Cell Carcinoma And Analysis Of Influencing Factors Of Tumor Specific Survival
80. Detection And Identification Of Abnormal DNA Methylation Pattern In Gene Promoter And Investigation Of The Relationship Between The DNA Methylation And Mutation In Early Non Small Cell Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to